Adjusted UCHL1 levels remained higher in symptomatic C9orf72 ALS compared to asymptomatic carriers (p = 0.008), but adjusted UCHL1 levels in C9orf72 FTD were similar to those in asymptomatic carriers (p = 0.367). Here, C9orf72 is linked to frontotemporal dementia.